Knight Cancer Institute
The Knight Cancer Institute at Oregon Health and Sciences University has earned an international reputation for innovative research, including early detection and cancer interception.
About the centre
The Knight Cancer Institute believes that scientific progress is built on creative ideas, advanced technology, tireless dedication, and teamwork.
The Knight Cancer Institute has been a member of the International Alliance for Cancer Early Detection (ACED) since our launch in 2019. It brings strengths in early detection, cancer interception, genomics and biofabrication. Its contributions to the ACED research themes include analysis of precursor lesions for pancreatic and ovarian cancers, investigating the role of obesity in pancreatic cancer progression, and community engagement in early cancer detection research.
Learn more about the Knight Cancer InstituteCore expertise and resources
precision early detection strategy and large-scale population studies, such as the Healthy Oregon Project
advanced bioengineering platforms, including 3D bioprinting, organoids and tissue chips for early tumour modelling
AI, computational biology and multi-omics data tools to model tumour initiation and predict progression
state‑of‑the‑art imaging technologies to study early tumour evolution and pre‑malignant states
strong biomarker discovery pipelines and early detection clinical trials across cancers
extensive training ecosystem, including PhD programmes, postdoctoral fellowships and interdisciplinary mentorship
Key contacts
Laura Heiser
Knight Cancer Institute ACED Centre Director
Nima Nabavizadeh
Knight Cancer Institute ACED Centre Deputy Director
James McGann
Knight Cancer Institute ACED Centre Interim Programme Manager